Navigation Links
Data on Xeomin® (incobotulinumtoxinA) in the Treatment of Blepharospasm to be Presented at the 115th Annual Meeting of the American Academy of Ophthalmology
Date:10/25/2011

ng or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or swallowing. When distant effects occur, additional respiratory muscles may be involved [See Boxed Warning]. Deaths as a complication of severe dysphagia have been reported after treatment with botulinum toxin. Dysphagia may persist for several months, and require use of a feeding tube to maintain adequate nutrition and hydration. Aspiration may result from severe dysphagia and is a particular risk when treating patients in whom swallowing or respiratory function is already compromised. These reactions can occur within hours to weeks after injection with botulinum toxin.
  • Cervical Dystonia: Patients with smaller neck muscle mass and patients who require bilateral injections into the sternocleidomastoid muscles are at greater risk of dysphagia. Limiting the dose injected into the sternocleidomastoid muscle may decrease the occurrence of dysphagia.

  • Blepharospasm: Injection of XEOMIN into the orbicularis oculi muscle may lead to reduced blinking and corneal exposure with possible ulceration or perforation. Lower lid injections should not be repeated if diplopia occurred with previous botulinum toxin injections.

  • Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junctional disorders (e.g., myasthenia gravis or Lambert-Eaton syndrome) should be monitored particularly closely when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including severe dysphagia and respiratory compromise from typical doses of XEOMIN.

  • ADVERSE REACTIONSCervical Dystonia: The most commonly observed adverse reactions (incidence greater than or equal to 10% of patients and twice the rate of placebo) for XEOMIN 120 Units
    '/>"/>

    SOURCE Merz Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. FDA Approves Merz Pharmaceuticals Xeomin® (incobotulinumtoxinA) for the Treatment of Cervical Dystonia and Blepharospasm
    2. Xeomin® (incobotulinumtoxinA) - a Botulinum Toxin Free From Accessory Proteins - Now Available in the U.S.
    3. Xeomin® (incobotulinumtoxinA) Data To Be Presented At The 71st Annual Assembly Of The American Academy Of Physical Medicine And Rehabilitation
    4. Merz Pharmaceuticals Introduces Comprehensive Programs to Provide Patients With Financial Assistance for Xeomin® (incobotulinumtoxinA)
    5. Merz Pharmaceuticals Announces New Centers for Medicare and Medicaid Billing Q-Code for Xeomin® (incobotulinumtoxinA)
    6. New Data On Xeomin® (IncobotulinumtoxinA) To Be Presented At The 15th International Congress Of Parkinsons Disease And Movement Disorders (MDS)
    7. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
    8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
    9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
    10. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
    11. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/17/2015)... The issue: In consultation with ... (lot 710535) of Clavulin-400 (70mL) after receiving a complaint from ... one bottle of the  product. No other lots of GSK ... is an oral antibiotic used in adults and children aged ... comes as a powder in bottles and is mixed with ...
    (Date:4/17/2015)... , April 17, 2015  Regulatory leaders in ... released bipartisan discussion draft called "21 st Century ... planned to be taken up by Congress soon and ... and medical device products are developed and marketed in ... reason, many companies have begun to consider how the ...
    (Date:4/17/2015)... Ill. , April 17, 2015  AbbVie Inc. ("AbbVie") ... announced that it has extended the expiration of its exchange ... stock of Pharmacyclics, Inc. to 5 p.m., New ... On April 17, 2015, AbbVie also voluntarily withdrew ... Improvements Act in order to provide the FTC with additional ...
    Breaking Medicine Technology:Advisory - Clavulin-400 liquid oral antibiotic: One lot recalled after glass pieces found in one bottle 221st Century Cures: A Regulatory Game-Changer for the Pharmaceutical Industry 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 2AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 3AbbVie Extends Exchange Offer to Acquire Pharmacyclics, Inc. 4
    (Date:4/18/2015)... 2015 The Residential Senior Care ... past five years. The industry, which provides residential and ... fully care for themselves, has boomed on account of ... care for seniors with memory impairment. As a result, ... rate of 4.1% to $1.9 billion over the five ...
    (Date:4/18/2015)... 18, 2015 Carinsurancesavings.biz has released a ... are cheaper during Spring. , Spring can ... plan. Drivers should make sure they compare the newest ... Clients can learn more about Spring car insurance offers ... Auto insurance quotes are becoming more and more popular. ...
    (Date:4/18/2015)... April 18, 2015 "I wanted ... to create a healthful juice that contained essential ... Rosedale, Md. "It increases my energy, improves skin ... , He developed Tapp's Juice to contain fruits, ... to prevent physical and mental fatigue. It features ...
    (Date:4/18/2015)... 18, 2015 Lowcostcarinsuranceprice.com has released a ... have on auto insurance prices . , ... of vehicle theft may have to pay more for ... auto insurance policies can also offer protection against vehicle ... be compared online on a single website: http://lowcostcarinsuranceprice.com/ ...
    (Date:4/18/2015)... York, New York (PRWEB) April 18, 2015 ... ) filed on behalf of individuals who were ... replacement system continue to move forward in the U.S. ... Order dated April 10th, the Court has amended an ... of unrelated cases. Among other things, the new amendment ...
    Breaking Medicine News(10 mins):Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Residential Senior Care Franchises in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Auto Insurance Plans Are Cheaper During Spring! 2Health News:High Rates Of Car Theft Can Have An Impact on Auto Insurance Prices! 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 2Health News:DePuy Pinnacle Hip Lawsuits: Federal Litigation Amends Case Management Order to Allow for Joinder of Unrelated Claims 3
    ... Quick Patient-Information Retrieval From Multiple Medical ... Dec. 14 AT&T Inc. (NYSE: ... Ltd. (JOHA) has,awarded AT&T a three-year contract ... to other network solutions. Continuing its relationship,as ...
    ... Lancet Oncology publication provides important insights on the ... Test in clinical practice -, AMSTERDAM, The ... MammaPrint(R) breast cancer prognosis test was,successfully implemented in ... hospitals in The Netherlands. MammaPrint(R) assigned,up to one- ...
    ... in the last several decades, but at least one advance ... rise in women in prevalence, morbidity and mortality. By 2000, ... of men. But the rising number of cases in women ... apparent gender-bias. , The disease expression of COPD in women ...
    ... CHICAGO, Dec. 13 Advanced Life Sciences,Holdings, Inc. ... in the,discovery, development and commercialization of novel drugs ... today announced,that it completed its private placement of ... warrants to purchase approximately 5.1,million shares of common ...
    ... Hologic, Inc.,(Nasdaq: HOLX ) announced today ... recommended that the pre-market application for,Adiana(R) Permanent Contraception ... decision by a vote of 10 to 3., ... but traditionally follows the,recommendations of its advisory panels. ...
    ... a scandal now ensnaring,some of the nations leading ... Wal-Mart, Costco, Target, Safeway, and Wild Oats of ... legal filings in federal courts in Seattle, Denver, ... heels of class action,lawsuits against Aurora Dairy Corporation, ...
    Cached Medicine News:Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 2Health News:Local Joliet Physician Group Selects AT&T for Managed Online Data Solutions 3Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 2Health News:Study Shows MammaPrint(R) Breast Cancer Test Provides Benefits to Patients from Personalized Treatment Regimen 3Health News:When disease discriminates: Women and COPD 2Health News:When disease discriminates: Women and COPD 3Health News:Advanced Life Sciences Completes Private Placement for $20 Million 2Health News:Advanced Life Sciences Completes Private Placement for $20 Million 3Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 2Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 3Health News:FDA Advisory Panel Finds Hologic's Adiana(R) Permanent Contraception Approvable 4Health News:Nation's Largest Retailers Accused of Organic Fraud 2
    Angled ring curette....
    Set of 5 large bone curettes. One each of the following: angled small, straight small, angled medium, straight medium, and angled large....
    Perisoteal rasp for elevating, dissecting, and scraping....
    Custom-made chisels....
    Medicine Products: